In breast cancer, the source of IL-30 was stromal leukocytes, and IL-30 stimulated the proliferation of breast cancer cells in a gp130/IL-6R- and STAT1/STAT3-mediated mechanism [105]. Here, IL6ST is linked to breast carcinoma.